Key product benefits
- Accelerate formation of cartilage
- Eliminate inflammation
- Expedite the healing process
- Increase joint fluid viscosity
- Enhance protective response of joint tissue
- Improve mobility and reduce pain
Integricare designed TRI-ACTA H.A. to be an effective joint treatment option for your pet that is experiencing age-related soreness, osteoarthritis, hip dysplasia, significant pain, or immobility. It can also be used to support joint healing after surgery. TRI-ACTA H.A. combines all the benefits of our regular TRI-ACTA formula with the addition of hyaluronic acid, which leads to improved viscosity of the synovial fluid in joints, providing maximum joint protection and excellent healing results. It is also designed to provide maximum protection against cartilage deterioration as well as actively repair worn-out cartilage.
TRI-ACTA H.A. has been designed to:
- Promote healthy cartilage
- Repair collagen and connective tissue
- Protect joint tissues
- Decrease stiffness
- Improve mobility
TRI-ACTA H.A. is optimal for:
- Visible signs of immobility due to age
- Moderate to advanced mobility concerns
- Pre and post surgery recovery
- Prevention for highly active pets
Dosage and Ingredients
EVERY 1 G (1000 MG) SERVING CONTAINS:
| Glucosamine (Glucosamine Sulfate 231 mg, Glucosamine HCL 231 mg) | 462 mg |
| Methylsulfonylmethane (MSM) | 443 mg |
| Chondroitin Sulfate | 88 mg |
| Hyaluronic Acid | 7 mg |
RECOMMENDED DAILY MAINTENANCE LEVEL:
| Under 10 lbs. (4.5kg) | 0.5 g |
| 10-35 lbs. (4.5-16 kg) | 1 g |
| 35-75 lbs. (16-35 kg) | 2g |
| 75-100 lbs. (35-50 kg) | 3g |
DIRECTIONS:
Using the measuring scoop provided, simply sprinkle desired amount on food.
For optimal results double the recommended daily maintenance level for up to 4 weeks. When desired improvement is noticeable, decrease dosage to the recommended maintenance level. The servings per dose may be divided over two meals daily.
The time to achieve a positive response will vary depending on the severity of each condition. If improvement is noticed within four weeks, proceed to the maintenance level. If not, continue the loading dose until the desired response is achieved and then reduce to the maintenance dose.